Lifestance Health
LFST
120 hedge funds and large institutions have $2.42B invested in Lifestance Health in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 40 reducing their positions, and 19 closing their positions.
18% more capital invested
Capital invested by funds: $2.05B → $2.42B (+$373M)
11% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 19
2.8% more ownership
Funds ownership: 78.95% → 81.75% (+2.8%)
1% more funds holding
Funds holding: 119 → 120 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
13% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 40
49% less call options, than puts
Call options by funds: $1.67M | Put options by funds: $3.27M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$41.3M |
| 2 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
+$39.7M |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
+$6.85M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$5.58M |
| 5 |
Goldman Sachs
New York
|
+$4.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SP
Stockbridge Partners
Boston,
Massachusetts
|
-$19.3M |
| 2 |
IHAM
Integral Health Asset Management
New York
|
-$8.93M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
-$2.65M |
| 4 |
Millennium Management
New York
|
-$2.4M |
| 5 |
PFA
Peak Financial Advisors
Denver,
Colorado
|
-$1.99M |
LFST Hedge Fund Activity: Q4 2023 in Review
120 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Lifestance Health (LFST) for Q4 2023, worth a combined $2.42B — up 18% from $2.05B a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new LFST positions and 19 closed out — a net gain of 2 holders — while 35 added to existing stakes and 40 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $41.3M. The largest seller was Stockbridge Partners, exiting entirely with an estimated $19.3M sold.
- 120 institutional investors held Lifestance Health (LFST) as of Q4 2023, up from 119 in Q3 2023.
- Funds reported $2.42B of Lifestance Health stock for Q4 2023, up 18% quarter-over-quarter.
- 21 funds opened new Lifestance Health positions in Q4 2023 and 19 closed out, a net change of +2 holders.
- The largest Lifestance Health buyer in Q4 2023 was Fidelity Investments, an estimated $41.3M added.
- The largest Lifestance Health seller in Q4 2023 was Stockbridge Partners, an estimated $19.3M sold.
Based on aggregated 13F filings for Q4 2023.